Lakshita Bhagtani transitioned from biotechnology to management studies at the University of Exeter, navigating the ...
Appoints accomplished commercial leader Chris Martin to its Board of DirectorsMENLO PARK, Calif., Dec. 11, 2025 (GLOBE ...
Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision ...
Experienced senior executive brings proven track record in financial strategy, operational excellence, and commercial execution ...
Tessera Therapeutics, the biotechnology company pioneering a new approach in genetic medicine known as Gene Writing™, today announced a planned leadership transition in its executive team. After ...
Moderna has hired veteran homeland security official David Parkin as its next Director of Threat Management, bringing a ...
Potent CAR-T expansion from a single, off-the-shelf infusion without chemotherapy ...
The Medical Assessment and Rating Board (MARB) of the National Medical Commission (NMC) has approved 4201 new postgraduate ...
Strand Therapeutics, a leader in next-generation mRNA-based therapeutics, today announced that former Nimbus Therapeutics CEO, Jeb Keiper, has joined Strand's Board as an independent Director to ...
Oncology Research Program (ORP) today announced new funding for advancing clinical research in metastatic breast cancer (mBC). Six grants have been awarded to support quality improvement projects ...
The 5th meeting of the Board of Studies of the Department of Natural and Basic Sciences at the University of Turbat (UoT) was held at UoT, under the chairmanship of Jahangir Khan Achakzai. The purpose ...
Berlin’s refusal to address its dysfunctional power market comes at the cost of Europe’s entire electrical grid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results